Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and ...

Researchers at the Max Planck Institute for Molecular Genetics have developed a novel synthetic micropeptide termed the ...

Looking at life today, it is difficult to imagine how complex biological processes and structures could have developed from ...

Scientists have begun the Synthetic Human Genome (SynHG) project, aiming to reconstruct human genetic material from scratch. The Wellcome Trust funds this ambitious initiative.

As if sequencing a full human genome wasn't tricky enough, scientists are now attempting to reconstruct our species' genetic ...

This surprising discovery opens the door to understanding how cells might organize internal processes ... Guest molecules ride perfect waves in dna droplets—A breakthrough for synthetic biology ...

Navigating the Artificial Blood Cells MarketIn the landscape of modern medicine, few innovations hold the transformative ...

Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit ...

Enduro Genetics, which specializes in synthetic biology, says they’ve developed genetic plugins featuring biosensors and promoters that can detect and regulate mAb production levels in cells.

Perovskite, discovered by scientists nearly 200 years ago, has only recently come to be seen as a promising element for ...

Get Instant Summarized Text (Gist) A synthetic lipoprotein targets the SR-B1 receptor on cancer cells, depleting the antioxidant enzyme GPx4 and inducing ferroptosis through increased lipid oxidation.